Literature DB >> 28612108

Surgical therapy of prostatitis: a systematic review.

Dominik S Schoeb1, Daniel Schlager2, Martin Boeker3, Ulrich Wetterauer2, Martin Schoenthaler2, Thomas R W Herrmann4, Arkadiusz Miernik2.   

Abstract

PURPOSE: The clinical term "prostatitis" refers to a clinical syndrome defined by the following 4 distinct entities: acute bacterial prostatitis (category 1), chronic bacterial prostatitis (category 2), chronic prostatitis/chronic pelvic pain syndrome (category 3), and asymptomatic prostatitis (category 4) The etiology of the chronic forms is still not fully understood and choice of therapy is often debated. The objective of this systematic review is to collect evidence on the surgical treatment of the chronic form of prostatitis and to evaluate its clinical implication.
METHODS: We performed a systematic literature search and identified 6683 relevant publications, of which 16 were included in the review.
RESULTS: Transurethral prostate resection was performed in 110 patients; 78 patients (70%) were reported as "cured", 16 patients (15%) as improved, and 16 patients (15%) as unchanged. Radical prostatectomy was performed in 21 patients; a full resolution of prostatitis related symptoms was reported for 20 patients (95%). No increased rates of complications or unusual complications were noted.
CONCLUSIONS: Surgical therapy of chronic bacterial prostatitis or chronic pelvic pain syndrome might be a viable option; however, since little evidence is currently available and no randomized controlled trials have been conducted, the presently available data does not provide a base for clinical decisions.

Entities:  

Keywords:  Lower urinary tract symptoms; Male; Pelvic pain; Prostatitis; Urologic surgical procedures

Mesh:

Year:  2017        PMID: 28612108     DOI: 10.1007/s00345-017-2054-0

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  58 in total

1.  A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).

Authors:  Volkan Tuğcu; Ali Ihsan Taşçi; Adem Fazlioğlu; Gökhan Gürbüz; Emin Ozbek; Selçuk Sahin; Fatih Kurtuluş; Mete Cek
Journal:  Eur Urol       Date:  2006-10-17       Impact factor: 20.096

2.  Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.

Authors:  Daniel A Shoskes; J Curtis Nickel; Michael W Kattan
Journal:  Urology       Date:  2010-04-03       Impact factor: 2.649

Review 3.  Pregabalin for chronic prostatitis.

Authors:  Omar M Aboumarzouk; Richard L Nelson
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

4.  Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study.

Authors:  Florian M E Wagenlehner; Stefania Ballarini; Kurt G Naber
Journal:  World J Urol       Date:  2014-01-31       Impact factor: 4.226

5.  Transurethral resection of the prostate in recurrent acute bacterial prostatitis.

Authors:  Karel Decaestecker; Willem Oosterlinck
Journal:  Urol Int       Date:  2014-11-04       Impact factor: 2.089

6.  A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Sylvia M Bates; Valerie A Hill; John B Anderson; Christopher R Chapple; Rosemary Spence; Claire Ryan; Martin D Talbot
Journal:  BJU Int       Date:  2007-02       Impact factor: 5.588

7.  Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments--could it represent a valid option? The physical activity and male pelvic pain trial: a double-blind, randomized study.

Authors:  Gianluca Giubilei; Nicola Mondaini; Andrea Minervini; Calogero Saieva; Alberto Lapini; Sergio Serni; Riccardo Bartoletti; Marco Carini
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

Review 8.  Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Authors:  Anthony J Schaeffer; Nand S Datta; Jackson E Fowler; John N Krieger; Mark S Litwin; Robert B Nadler; J Curtis Nickel; Michel A Pontari; Daniel A Shoskes; Scott I Zeitlin; Carol Hart
Journal:  Urology       Date:  2002-12       Impact factor: 2.649

9.  Feasibility of robotic radical prostatectomy for medication refractory chronic prostatitis/chronic pelvic pain syndrome: Initial results.

Authors:  Sameer Chopra; Raj Satkunasivam; Monish Aron
Journal:  Indian J Urol       Date:  2016 Jul-Sep

10.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12
View more
  2 in total

1.  Chronic prostatitis effectively managed by transurethral prostatectomy (TURP) in a spinal cord injury male.

Authors:  Charalampos Konstantinidis; Achileas Karafotias; Ioannis Eleftheropoulos; Dimitrios Delakas
Journal:  Spinal Cord Ser Cases       Date:  2019-09-23

Review 2.  Pharmacological Interventions for Bacterial Prostatitis.

Authors:  Situ Xiong; Xiaoqiang Liu; Wen Deng; Zhengtao Zhou; Yulei Li; Yechao Tu; Luyao Chen; Gongxian Wang; Bin Fu
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.